Summit Therapeutics: Major Upcoming Ivonescimab Data Catalyst May Not Be All It Seems (Rating Downgrade)
Summit Therapeutics' ivonescimab outperforms Keytruda in Phase 3 lung cancer trials. Crucial Western market approval depends ...
Q4 2024 SeaStar Medical Holding Corp Earnings Call
At this time, I would like to welcome everyone to the SeaStar Medical year-end 2024 financial results conference call. (Operator Instructions) Thank you. I would now like to turn the call over to ...
Bureau of Meteorology22h
Climate Model Summary (discontinued)
We are streamlining some climate pages including removal of the Model Summary. From 10 December our climate information is available on the Southern Hemisphere monitoring and Southern Hemisphere ...